4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-23-017407
Head of R&D, CSO gave up 1,134 shares (to pay taxes)
- Head of R&D, CSO acquired 4,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Rodino-Klapac Louise · Head of R&D, CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-06 | Shares withheld for taxes : show line 1 in the form | −1,134 | $157.21 | $178,276 | 66,582 | D |
| 2023-03-06 | Grant or award : show line 2 in the form | +4,500 | 71,082 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-06 | Grant or award : show line 3 in the form Stock Option (right to buy) | +27,000 | 27,000 | D |
Loading xslF345X03/doc4.xml…